Skip to main content

Abstract

We investigate the effects of Clostridium butyricum(CB) on gut microbiota and colitis associated colon cancer(CAC) in mice.6-8 weeks old C57BL/6 mice were randomly divided into control, azoxymethane (AOM) + dextran sodium sulphate (DSS) and AOM + DSS + CB groups. Mice in the latter two groups received an intraperitoneal injection of AOM (12.5 mg/kg), followed by three cycles of DSS diluted in water (2.5% w/v). Mice in treatment group received CB (2 × 108 CFU in 200 ul normal saline) by gavage administration three times one week. Microbiota composition was assessed by 16S rRNA high-throughput sequencing. Colon samples were collected to examine severity of colitis and tumorigenesis. Cytokines including TNF-a, IL-6 and Cyclo-oxygenase-2 (COX-2) were detected by RT-qPCR. Expression of Bcl-2, Bax and the state of components of NF-κB signaling pathway were detected by western blot. The results revealed that CB regulated structure of intestinal flora and changed the microbial composition; decreased Firmicutes/ Bacteroidetes ratio in phylum level and increased the relative abundance of probiotics; decreased colitis, decreased incidence and size of colorectal cancer(CRC) and increased apoptosis of tumor cells; decreased cytokines including TNF-a and IL-6; decreased level of COX-2; decreased phosphorylation of NF-κB; decreased level of Bcl-2 and increased expression of Bax. In conclusion, CB could regulate structure and composition of gut microbiota and reduces colitis associated colon cancer in mice, the mechanism may be inhibiting NF-κB pathway and promoting apoptosis.

Keywords: Clostridium Butyricum; Colitis associated colon cancer; Gut microbiota; NF-κB Signaling Pathway.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Clostridium butyricumIncreased Tumor Cell ApoptosisBeneficial
Large
Clostridium butyricumOptimized Gut Microbiota CompositionBeneficial
Moderate
Clostridium butyricumReduced COX-2 LevelsBeneficial
Moderate
Clostridium butyricumReduced NF-κB Pathway ActivityBeneficial
Moderate
Clostridium butyricumReduced Pro-Inflammatory CytokinesBeneficial
Moderate
Clostridium butyricumReduced Risk of Colorectal CancerBeneficial
Large
Clostridium butyricumReduced Severity of Acute ColitisBeneficial
Large

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.